Articles by author - Aleksandra Jawiarczyk

Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly.

Jawiarczyk A, Kałuzny M, Bolanowski M, Bednarek-Tupikowska G.

Clinical Trial 2008; 29(4): 571-576 PubMed PMID: 18766168  Keywords:  Acromegaly:drug therapy, Adult, Aged, Antineoplastic Agents, Hormonal:therapeutic use, Drug Therapy, Combination, Female, Growth Hormone:blood, Human Growth Hormone:analogs & derivatives, Humans, Insulin-Like Growth Factor I:metabolism, Male, Middle Aged,.    Citation

OBJECTIVE: Somatostatin analogs, dopamine agonists and GH-receptor antagonist--pegvisomant are used in medical therapy of acromegaly. Sinc.....

Read abstract  Full text PDF

The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.

Zadrozna-Sliwka B, Bolanowski M, Jawiarczyk A, Kaluzny M, Syrycka J.

Journal Article 2008; 29(1): 178-184 PubMed PMID: 18283239  Keywords:  Adult, Alkaline Phosphatase:blood, Bone Density:physiology, Bone Diseases, Metabolic:blood, Bone and Bones:metabolism, Case-Control Studies, Female, Humans, Hyperprolactinemia:blood, Middle Aged, Parathyroid Hormone:blood, Peptide Fragments:blood, Prognos.    Citation

OBJECTIVES: Hyperprolactinemia could be one of possible causes of bone loss. The reason is thought to be connected with hypogonadism due t.....

Read abstract  Full text PDF